Skip to main content

USPSTF: Evidence Lacking for Screening for Lipid Disorders in Patients Aged 20 and Younger

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

TUESDAY, July 18, 2023 -- The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient for assessing the balance of benefits and harms of screening for lipid disorders in children and adolescents aged 20 years or younger. These findings form the basis of a final recommendation statement published in the July 18 issue of the Journal of the American Medical Association.

Janelle M. Guirguis-Blake, M.D., from the Kaiser Permanente Evidence-based Practice Center in Portland, Oregon, and colleagues reviewed the benefits and harms of screening and treatment of pediatric dyslipidemia due to familial hypercholesterolemia (FH) and multifactorial dyslipidemia. Data were included from 43 studies with 491,516 participants. The researchers found that no randomized clinical trials (RCTs) directly addressed the effectiveness and harms of screening. The prevalence of phenotypically defined FH was 0.2 to 0.4 percent in three U.S. studies, and the prevalence of elevated total cholesterol and of any lipid abnormality was 7.1 to 9.4 percent and 19.2 percent, respectively. Statins were associated with an 81- to 82-mg/dL greater mean reduction in levels of total cholesterol and low-density lipoprotein cholesterol compared with placebo at two years based on 10 RCTs. Statin treatment for FH starting in childhood or adolescence reduced long-term cardiovascular disease risk in observational studies.

Based on these findings, the USPSTF concludes that the current evidence is insufficient for assessing the balance of benefits and harms of lipid disorder screening among asymptomatic children and adolescents aged 20 years or younger (I statement).

"We don't have enough evidence to tell us whether or not screening all children and adolescents for high cholesterol is beneficial," a task force member said in a statement.

Evidence Report

Final Recommendation Statement

Editorial

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2023

Read this next

First Responders With More Debris Exposure Have Higher Risk of Early Dementia

FRIDAY, June 14, 2024 -- More severe exposure to dust or debris among World Trade Center (WTC) responders is significantly associated with a higher risk of dementia at <65...

1990 to 2019 Saw Increase in Life Expectancy in Seniors With T1DM

FRIDAY, June 14, 2024 -- From 1990 to 2019, there was an increase in life expectancy in older people with type 1 diabetes mellitus (T1DM), according to a study published online...

Second Tumors Are Rare After Chimeric Antigen Receptor T-Cell Therapy

FRIDAY, June 14, 2024 -- Second tumors are rarely seen after chimeric antigen receptor (CAR) T-cell therapy, according to a study published in the June 13 issue of the New England...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.